Drug Profile
R 1438
Alternative Names: R-1438Latest Information Update: 19 Oct 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 19 Oct 2006 Discontinued - Phase-II for Type-2 diabetes mellitus in Europe (unspecified route)
- 30 Jun 2005 Phase-II clinical trials in Type-2 diabetes mellitus in Europe (unspecified route)
- 26 May 2003 Phase-I clinical trials in Type-2 diabetes mellitus in Europe (unspecified route)